Chemical activators of C3orf43 include a variety of compounds that initiate signaling cascades resulting in the protein's activation. Forskolin is known to directly activate adenylate cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). This rise in cAMP levels can lead to the activation of protein kinase A (PKA), a kinase that can phosphorylate and activate C3orf43. Similarly, Isoproterenol, a beta-adrenergic agonist, elevates cAMP levels, following the same pathway to activate C3orf43 via PKA. Another chemical, Ionomycin, functions by increasing intracellular calcium levels, which can then activate C3orf43 through calmodulin-dependent kinases, enzymes that are sensitive to changes in calcium ion concentrations in the cell. Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC) and can directly phosphorylate proteins like C3orf43, leading to its activation.
Additionally, Calyculin A and Okadaic Acid are inhibitors of protein phosphatases, which normally dephosphorylate and deactivate proteins. By inhibiting these phosphatases, these chemicals can result in an overall increase in the phosphorylation and subsequent activation of C3orf43. Anisomycin activates the MAPK/ERK pathway, which is known to phosphorylate a wide range of proteins, including C3orf43, thereby promoting its activation. Inhibition of phosphoinositide 3-kinases (PI3K) by LY294002 can lead to compensatory cellular responses that may activate C3orf43, while U0126, a MEK inhibitor, can induce similar compensatory mechanisms leading to the activation of C3orf43. Epigallocatechin gallate (EGCG) inhibits a spectrum of protein kinases, causing alterations in cellular signaling networks that can lead to the activation of C3orf43. Dibutyryl-cAMP, being a cAMP analog, can bind and activate PKA, leading directly to the activation of C3orf43. Lastly, Sodium Fluoride activates the MAPK/ERK pathway, which is another potential route through which C3orf43 can be phosphorylated and activated. These chemicals, through their various actions on intracellular signaling pathways and enzymes, can all contribute to the activation of C3orf43.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that increases cAMP, leading to C3orf43 activation through PKA. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, which can activate C3orf43 through calmodulin-dependent kinases. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Directly activates PKC which can phosphorylate and activate C3orf43. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases leading to increased phosphorylation and activation of C3orf43. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases, potentially resulting in the activation of C3orf43. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates MAPK/ERK pathway which can lead to phosphorylation and activation of C3orf43. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially leading to compensatory activation of C3orf43. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, which may lead to compensatory activation of pathways activating C3orf43. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits several protein kinases, which may lead to network changes activating C3orf43. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that directly activates PKA, leading to activation of C3orf43. | ||||||